Similar companies
Company | Revenue | |
---|---|---|
![]() |
Intuitive SurgicalISRG |
2.55B 14% |
Income Statement (USD)
Q4 '24 | QoQ | |
---|---|---|
Revenue | 6.44B | 17.1% |
Gross Profit | 4.17B | 18.7% |
Cost of Revenue | 2.26B | 14.4% |
Operating expense | 3.59B | 47.7% |
Net Income | 546M | 34.5% |
EBITDA | 737M | 40.8% |
Balance Sheet (USD)
Q4 '24 | QoQ | |
---|---|---|
Total Assets | 43B | 2% |
Total Liabilities | 22.3B | 5.7% |
Total Equity | 20.6B | 2.4% |
Shares Outstanding | 381M | 0.1% |
Cash Flow (USD)
Q4 '24 | QoQ | |
---|---|---|
Cash from operations | 1.93B | 31% |
Cash from investing | -303M | 86% |
Cash from financing | -1.79B | 167.6% |
EPS
Financial Highlights for Stryker in Q4 '24
Stryker reported a revenue of 6.44B, which is a 17.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 4.17B, marking a 18.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.26B, a 14.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 3.59B, showing a 47.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 546M, showing a -34.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 737M, showing a -40.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Stryker faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.